Results of Cox proportional hazards model analysis for PSA failure
Covariates adjusted fora . | VDR FokI genotypeb . | . | . | . | |||
---|---|---|---|---|---|---|---|
. | Ff . | . | ff . | . | |||
. | HR . | 95% CI . | HR . | 95% CI . | |||
Age | 1.02 | 0.66–1.58 | 0.76 | 0.44–1.32 | |||
Age, Gleason grade, cancer, volume, and preoperative serum PSA | 1.07 | 0.68–1.69 | 1.03 | 0.58–1.85 |
Covariates adjusted fora . | VDR FokI genotypeb . | . | . | . | |||
---|---|---|---|---|---|---|---|
. | Ff . | . | ff . | . | |||
. | HR . | 95% CI . | HR . | 95% CI . | |||
Age | 1.02 | 0.66–1.58 | 0.76 | 0.44–1.32 | |||
Age, Gleason grade, cancer, volume, and preoperative serum PSA | 1.07 | 0.68–1.69 | 1.03 | 0.58–1.85 |
The following categories were used: age at surgery in years (<60, 60–64, 65–69, 70+); % Gleason grade 4/5 (<15%, 15–34%, 35–69%, ≥70%); cancer volume in cc (<2.00, 2.00–3.25, 3.26–6.68, ≥6.69); and preoperative serum PSA level in ng/ml (<9.1, 9.1–14.8, 14.9–24.9, ≥25.0).
The FF genotype was considered as a reference category.